Literature DB >> 28570935

Pharmacokinetics study of Erhuang decoction extracts in rats by HPLC-MS/MS.

Jinglong Wang1, Dandan Zheng2, Yingzi Wang3, Chao Zhang4, Xiumei Sun4.   

Abstract

To study the pharmacokinetics of Erhuang decoction extracts, a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was established for the determination of effective substances in rat plasma. The extracts prepared by water extraction (WE) method were given to rats by oral administration. After collected from the orbital venous plexus, plasma was treated by protein precipitation method. Then, the concentration of index components, including baicalin, liquiritin, berberine, palmatine and glycyrrhetinic acid, were determined by HPLC-MS/MS. Gradient elution mode was used to the chromatographic separation with an Inertsil ODS-SP column (100 mm×2.1mm, 5μm), with acetonitrile and 0.1% formic acid containing 10mmolL-1 ammonium acetate as the mobile phase. MS analysis was conducted by multiple reactions monitoring (MRM) with Electrospray Ionization (ESI). The extraction recoveries of the five active ingredients from plasma were greater than 86.04%, and the intra- and inter-day precisions were less than 16.57%. Results indicated that active ingredients in plasma of rats with oral administration of extracts showed certain difference in the pharmacokinetic parameters, which proved that the active ingredients were effectively absorbed. The established HPLC-MS/MS analytical method was sensitive and accurate, suitable for the pharmacokinetic study of active ingredients in Erhuang decoction.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Active ingredients; Erhuang decoction; HPLC–MS/MS; Pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 28570935     DOI: 10.1016/j.jchromb.2017.05.019

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  MTA1 aggravates experimental colitis in mice by promoting transcription factor HIF1A and up-regulating AQP4 expression.

Authors:  Ping Li; Dong-Ping Shi; Tao Jin; Dong Tang; Wei Wang; Liu-Hua Wang
Journal:  Cell Death Discov       Date:  2022-06-28

2.  Development and In Vitro and In Vivo Evaluation of Microspheres Containing Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate for the Oral Delivery of Berberine Hydrochloride.

Authors:  Ying Li; Chunyan Zhu
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

3.  A simple method for evaluation pharmacokinetics of glycyrrhetinic acid and potential drug-drug interaction between herbal ingredients.

Authors:  Neng Zhou; Caiyuan Zou; Menglin Qin; Yi Li; Jiayi Huang
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.